Drug Discovery Market Projected to Reach $8.52 Billion by 2030

AI Drug Discovery Market – a recent market report forecasts the global AI‑driven drug discovery sector to reach $8.52 billion by 2030, driven by expanding adoption of machine‑learning platforms for target identification and compound screening across pharma companies.

China’s BIO 2026 Conference – highlighted the first AI‑discovered drug candidates that achieved clinical proof, demonstrating that AI models can progress from in‑silico design to human trials, a milestone cited by event organizers as proof of concept for AI in therapeutics.

Industry Analysts – emphasize that closing the data loop, where experimental results continuously feed AI algorithms, is shortening development cycles, while reports such as “Closing the Data Loop in AI‑Driven Drug Discovery” stress improved model accuracy and reduced R&D costs.

Scientific Publications – recent articles in Nature, Oxford Academic and the World Economic Forum underline AI’s role in enhancing drug discovery and development, noting faster target validation, better compound prioritization and a shift toward data‑centric research pipelines.